Logo LMU Klinikum
  • Startseite
  • Einrichtungen
  • Kontakt
  • Presse
  • International Patient Office
  • en
    • Deutsch - de
    • English - en
Ukraine-Hilfe Notfall
  • Medizin & Pflege
    • Einrichtungen
      • Kliniken
      • Abteilungen
      • Institute
      • Zentren
      • Post-Covid Ambulanz
      Bereiche
      • Pflege
      • Krankenhaushygiene
      • Qualitätsmanagement
      • Apotheke
      • Transplantationsbeauftragte
  • Patienten & Besucher
      • Patienten
      • Besucher
      • Service und Unterstützung
      • Anfahrt und Parken
      • Wichtige Dokumente
  • Forschung
  • Lehre
  • Das Klinikum
      • Wir über uns
      • Zentrale Bereiche
      • Historie
      • Standorte
      • Publikationen
      • Amtliche Veröffentlichungen
  • Karriere
      • Stellenanzeigen
      • Berufsgruppen
      • Benefits
      • Berufsausbildung
      • Freiwilligendienste
      • LMU Health Academy
  • Aktuelles
      • Newsmeldungen 
      • Veranstaltungen
      • Pressemitteilungen
Abteilung für Klinische Pharmakologie
  1. Startseite LMU Klinikum
  2. Abteilung für Klinische Pharmakologie
  3. Research Groups
  4. Kobold Lab
  • Division Office
     
    • Research Groups
      • Division Head, Office, Project Management and Lab Assistance
         
      • Kobold Lab
         
      • Rothenfußer Lab
         
      • König and Schnurr Lab
         
      • Anz Lab
         
      • Daniel Lab
         
      • Research
        • Completed doctoral theses
           
          • Doctoral research programs
             
            • Habilitations
               
              • Alumni professors
                 
                • Grants
                   
                • Cooperations
                   
                  • Press releases
                     
                    • Ranking
                       
                      • Themes
                         
                      • Publications
                         
                      • Patient Care
                         
                        • Teaching
                           
                        • Medical Specialties
                           
                          • Events
                             
                          • News
                             
                            • i-Target 2.0
                              • Team Jobs
                                 
                                • Seminar Program
                                   
                                  • Graduate Students
                                     
                                    • Partnership Harvard Medical School
                                       
                                    • Annual Retreats
                                       
                                      • i-Target 1.0
                                        • Research Groups
                                          • Research area 1: Targeted cellular therapy
                                             
                                            • Research area 2: Targeted antibody therapy
                                               
                                              • Research area 3: Targeted immunomodulatory therapy
                                                 
                                              • Project Leaders
                                                 
                                                • Graduate Students
                                                   
                                                  • Publications
                                                     
                                                    • Annual Retreats
                                                      • 2016
                                                        • Introduction
                                                           
                                                          • Invitation Letter
                                                             
                                                            • Program
                                                               
                                                              • Confirmed Speakers
                                                                 
                                                                • Conference Venue
                                                                   
                                                              • Seminars
                                                                 
                                                                • Team Jobs
                                                                   
                                                                  • Partnership Harvard Medical School
                                                                     

                                                                Kobold Lab

                                                                Immunopharmacology - AG Kobold

                                                                • Gruppenbild AG Kobold

                                                                  Prof. Dr. med. Sebastian Kobold

                                                                  Principal Investigator

                                                                  Lindwurmstraße 2a
                                                                  80337 München
                                                                  089/4400-5 7325 089/4400-5 7330
                                                                  cnijgcblgu oüjüä;mvimsful_vfiuyziuemi
                                                                  CV
                                                                  Research Topics

                                                                  1. CAR T-cell therapy against solid tumors and leukemias

                                                                  2. Enabling add-on-strategies for cellular therapies in solid tumors

                                                                  3. Antibody therapies against several cancer entities

                                                                  4. Influence of the cytokine Interleukin-22 on promoting tumor growth and metastases

                                                                  Grants and Networks

                                                                  CONTRACT

                                                                  Präklinische konfirmatorische Studie zum Nutzen des C-C-Motiv Rezeptor-8 in der Anlockung von Antigen-spezifischen T-Zellen zu Tumoren für die Krebsbehandlung

                                                                  Funder: BMBF

                                                                  LETS immun CRC TRR338

                                                                  Erkrankungsspezifische Modifikation von CAR T-Zellen mit Chemokinrezeptoren.

                                                                  Funder: DFG

                                                                  T-OP

                                                                  Training Network for Optimizing Adoptive T cell Therapy of Cancer

                                                                  Funder: EU Horizon 2020 MSC-ITN 

                                                                  IOLIN

                                                                  Physician scientist program "immunooncology and local interventions" 

                                                                  Funder: EKFS 

                                                                  i-Target

                                                                  Immunotargeting of cancer. International training program of the Elitenetzwerk Bayern.

                                                                  ARMOR-T

                                                                  Arming multifunctional T cells for cancer therapy 

                                                                  Funder: EU Horizon 2020 ERC 

                                                                  BAYCELLator

                                                                  The Bavarian Cell Therapy Catalyst

                                                                  Funder: Bayerische Forschungsstiftung 


                                                                  T-RAFIC

                                                                  Tracking and controlling therapeutic immune cells in cancer

                                                                  Funder: Horizon Europe MSCA


                                                                • Welcome to the homepage of the Kobold lab “immunopharmacology“!

                                                                  The goal of our group is to contribute to preclinical development and advancement of novel drugs and immunotherapies against human’s biggest foe: cancer.

                                                                  Research topics and goals

                                                                  Within this raising field of immuno-oncology, we mainly focus on engineering of genetically modified T cells, with not only the famous Chimeric Antigen Receptor (CAR) T cells, but also own proprietary platforms, in several solid tumor type and leukemias. Within this field, we further develop approaches to enhance T cell´s full potential to approach and kill tumor cells via tumor infiltration and trafficking, T cell activation despite antigen escape and inhibition of local immunosuppression within the tumor microenvironment (TME) in vitro and in vivo. [Publications: 1, 2, 3, 4, 5, 6, 7]

                                                                  In addition, we also examine how bi- and polyspecific antibodies may bring T cells in the proximity of tumor cells both for enhanced killing in vitro and survival in vivo [Publication: 8]. As the majority of these novel and uncharted approaches to attack solid tumors and leukemias are not approved the Food and Drug Administration (FDA) or the European Medicines Agency (EMA), our mission is clear: To Make That Happen.

                                                                  Our group also investigates the interactions of tumor cells and the immune system within the tumor microenvironment (TME), especially at the level of cytokines secreted by tumor and immune cells. For example, we were able to identify the cytokine Interleukin-22 as a unique protein, as it is secreted by immune cells within the TME, but acts on its native Interleukin-22 receptor on tumor cells to promote cancer progression in several cancer models. In our work, we examine its detailed interaction partners and implications for immune cell exhaustion in vitro and in vivo [Publications: 9, 10]. 

                                                                  As very little is known about its pro-tumoral and pro-metastastic characteristic,our mission is clear: To Shed Light On The Mechanisms Behind.

                                                                  Challenges for CAR T-cell therapy in solid tumors

                                                                • Principal Investigator

                                                                  Prof. Dr. med. Sebastian Kobold

                                                                  I studied medicine in Bordeaux, Homburg and Zurich and performed my doctoral thesis in the laboratory of C. Renner and A. Knuth in Zurich. After graduating from medical school, I started my residency in Hamburg and worked with D. Atanackovic in the field of tumor immunology. After a stay at Dana-Farber Cancer Institute, Boston, I established my own research group at the University hospital of the LMU. I am a board certified immunologist and clinical pharmacologist. Since 2019, I serve as Professor of Medicine and Experimental Immunooncology and as deputy director of the Division of Clinical Pharmacology at the University Hospital of the LMU. My research is focused on developing and testing novel strategies to treat cancer using the immune system. My goal is to bring these innovations to the clinics to the benefit of patients affected from cancer. Most of my free time is dedicated to my family and in what might be left of it, I run.

                                                                  089 4400-57325
                                                                  dcijgcbSlgu-oüjüämvimsful_vdfiuyziu-mi
                                                                  CV

                                                                  Projektmanagement

                                                                  Simone Gautier, M.A. , M.E.U.S

                                                                  Projektmanagement T-OP (since 2016)

                                                                  clvüui-xgfblipvimsfulGvfiuyziusmi
                                                                  T-OP

                                                                  Dr. rer. nat. Kerstin Althaus

                                                                  Projektmanagement IOLIN (since 2023)

                                                                  oipcbluegäbzgfcvimsfulGvfiuyziu mi
                                                                  IOLIN

                                                                  Dr. rer. nat. Rosa Elena Andrade Aguirre

                                                                  Projektmanagement BAYCELLator (since 2023)

                                                                  pücgsg,umnpgmiv:im-ful#vfiuyzi,u-mi
                                                                  BAYCELLAtor

                                                                  Technical assistants

                                                                  Susanne Wenk

                                                                  CTA

                                                                  cfcguuiséiuodnvim-ful_vWfiuyziu mi
                                                                  More about

                                                                  I did my CTA education in Munich and started my first position at the GSF Munich GH (today: Helmholtz Zentrum). After my parental time I came back to University Hospital of the LMU. In the Division of Clinical Pharmacology at the University Hospital of the LMU I worked in different groups and since 2011 in the group of Prof. Dr. Sebastian Kobold. I have been responsible for a lot of different things, as e.g. for the organization of the relocation of the whole division to the Kubus 2015. Now, my primary responsibility is to manage the Kobold lab and to introduce all new members to their new working environment. My goal is to take care that we work in a nice and friendly atmosphere and help wherever I can. In my spare time I like to go hiking, skiing, sailing and traveling around the world with my family and friends. I try to ride my bike as often as I can.

                                                                  Disha Shah

                                                                  TA (since 2025)

                                                                  Mlczg RzgzvimsfuSl_vfiuyziu-mi

                                                                  Weronika Szulejko

                                                                  TA (since 2025)

                                                                  Uipüulog/Rßfäikoüvim ful_vfiuyziu mi

                                                                  Postdocs

                                                                  Dr. rer. nat. Daria Briukhovetska

                                                                  Post-Doc (since 2018)

                                                                  mgplgtjplfozüqibcoSgvimD ful+vfiuyziuemi

                                                                  Dr. med. Adrian Gottschlich

                                                                  Post-Doc (since 2019)

                                                                  gmplgue;xübbcyzälyzvim/ful_vfiuyziu mi

                                                                  Dr. med. Sophia Stock, MHBA

                                                                  Post-Doc

                                                                  cüözlg cbüyovim ful_vfiuyaziuJemi
                                                                  More about

                                                                  I studied Human Medicine at the Heidelberg University and Paris Descartes University. I performed my doctoral thesis in the laboratory of M. Schmitt in Heidelberg. After graduating from medical school, I started my residency in the hematology and oncology department at the University Hospital of the LMU Munich. I joined the working group of M. Subklewe in the field of translational cancer immunology. Since September 2020, I have been a fellow of the DKTK School of Oncology. Due to the support of the Else Kröner-Fresenius Clinician Scientist Program Cancer Immunotherapy and the Munich Clinician Scientist Program (MCSP) I have worked as a postdoctoral researcher in the working group of S. Kobold since April 2021. My ambition is to work as a Clinician Scientist specializing on immunotherapy. I spend most of my free time with my family and friends.

                                                                  Dr. rer. nat. Donjete Simnica

                                                                  Post-Doc (since 2022)

                                                                  müukibisclYvulygvim ful_vnWfiuyziu-nmi
                                                                  More about

                                                                  I studied nutritional sciences in Hamburg and Munich. My master´s thesis, which I conducted in Cork/Ireland, focused on the interplay of immune cells and pain receptors in inflammatory bowel diseases. Back in Germany, I entered the field of immune receptor repertoires in the group of Prof. Dr. Mascha Binder where I also obtained my PhD in December 2020. Using high-throughput sequencing and bioinformatic methods we set out to find immune repertoire imprints that help to identify patients who benefit from immune therapies. My research in the group of Prof. Dr. Sebastian Kobold focuses on the identfication of tumor-specific targets and subsequent design and testing of novel immune cell therapies. Future goals include to learn more about our fascinating immune cells and use this knowledge to generate potent treatments from which hopefully many patients can benefit. In my free time I like to do yoga, go running and practice on my keyboard.

                                                                  Dr. med. Ngoc-Thien-Thu Nguyen

                                                                  Post-Doc

                                                                  bzf/uxfјiuYvimdsfulGvfiuyziud mi

                                                                  Dr. phil. Marcel Trefny

                                                                  Post-Doc

                                                                  vgpyiäebpiwuјvim ful_vfiuyziJu mi

                                                                  Sayantan Nandi, Ph. D.

                                                                  Research Assistent (since 2022)

                                                                  RgјgubgueTgumlvim ful_vfiuynziusmi

                                                                  Arman Öner, Dr. med.

                                                                  Post-Doc

                                                                  gpvguJ-üiuipvim-fualrvfiuyziuemi

                                                                  Janina Dörr, Ph. D.

                                                                  Post-Doc (since 2024)

                                                                  kSgulug-müSippdvimsful+vfiuyziud-mi

                                                                  Natasha Samson, Ph. D. 

                                                                  Post-Doc (since 2024)

                                                                  STgbgczg-Rgvcüuvimsful#vfiuynzWiusm,i

                                                                  Stefanos Michaelides

                                                                  Post-Doc (since 2025)

                                                                  Dr. med.                    Tengis Tschaidse

                                                                  Post-Doc (since 2025)

                                                                  Doctoral researchers

                                                                  Lisa Gregor

                                                                  äSlcg xpixüpvim-fulrvfiuyziu mi
                                                                  More about

                                                                  I studied General Biology in my bachelor’s during which I investigated mechanisms of epigenetics and the methyltransferase Dnmt1 in the group of H. Leonhardt. Throughout my master’s degree in Human Biology at the LMU I focused on Immunology and Molecular Oncology, where I studied the combined therapeutic benefits of radio- and immunotherapy in cancer in the group of O. Boyman in Zürich, Switzerland. I started my PhD during fall 2021 in the Kobold Lab, where I now work on the development of cellular therapies for solid tumor entities. My free time I mostly spend with friends and family, I like travelling, eating, and enjoying life without a pipette in my hand!

                                                                  Emanuele Carlini, M. Sc.

                                                                  :ivgufiäitygpäluJlvimsful+vfiuyziu mi
                                                                  More about

                                                                  I graduated from King's College London with a Bachelor's in Pharmacology and from ETH Zurich with a Master's in Pharmaceutical Sciences. After conducting my Master Thesis at the University Hospital of Basel, focusing on immunology and cancer immunotherapy, I moved to Munich for my PhD studies.

                                                                  At LMU, my work is concerned with investigating how to properly harness the function of cytokines to support and improve the efficacy of cellular therapies against cancer via the generation of chimeric cytokine receptors.

                                                                  David Andreu Sanz, M. Sc.

                                                                  mgqlm gumpifvimJefdulY+vfiuyziuemi
                                                                  More about

                                                                  I am a biotechnologist from Barcelona with a master’s in biomedical research. During my bachelor's studies, I had the chance to explore very different areas of research, including transcriptomics and embryology. During my master’s degree, I discovered my interest in cancer cell therapy and conducted my master thesis in Coquet lab at Karolinska Institutet in the field of tumor immunology. I am currently part of the Marie Skłodowska-Curie training network for Optimizing Adoptive T Cell Therapy of Cancer (T-OP) and my PhD project aims to improve CAR T cell functionality with cytokine signaling. In my free time I enjoy playing the piano and learning languages.

                                                                  Mara Henrich

                                                                  doctoral researcher (PhD track) (since 2023)

                                                                  vgpg ziuplyzvimtfulhvfiuySziueSmi

                                                                  Philipp Jie Müller 

                                                                  doctoral researcher (MD track)

                                                                  özevfiääipvim-ful_vfiuyziu mi
                                                                  More about

                                                                  As I finished my high school diploma in Pforzheim in 2018, my dream came true to study medicine in Bavarian’s metropolitan area Munich. After the preclinical studies at the Luwig-Maximilians-University Munich and the first state examination in summer 2020, I continued the clinical part of my degree at the Technical University of Munich and the Klinikum rechts der Isar. At the DoktaMed 2020, I experienced the KlinPharm and the Kobold lab the first time, and was thrilled of their working spirit and future goals. Fortunately, my time within our group started in August 2021, as my first day was a pretty memorable hike from Schliersee to Tegernsee. To current state, I am working on the roles of cytokines in immune cell crosstalk and cancer progression, in particular the cytokine Interleukin-22 and its influence on metastases spreading. Besides, my work also includes doing immunofluorescence miscrocopy on human lung cancer tissues to ameliorate the understanding of Interleukin-22-secreting cells as well as their interaction partners. This brings me to my goals, to contribute to the everlasting work for improved understanting of cancer and its possible therapies. Concerning the future, it is my goal to further pursue research activities and at the same time clinical work with cancer patients on the university hospital level. After a hard lab day, I love to enjoy the best noodle place in Munich, the Max Beef Noodles Restaurant at the Sendlinger Tor. In addition, if I am not thinking of any lab work or clinical cases, I spent my leisure time pubquizzing with friends, biking in and around Munich, hiking in the alps and playing the guitar to four chord music hits.

                                                                  Vivien Menkhoff 

                                                                  doctoral researcher (MD track, FöFoLe) (since 2023)

                                                                  qlqliusviuozüwwvim ful_vfiuyziu mi
                                                                  More about

                                                                  I have been a medical student at LMU Munich for nine semesters now and have just started doing research for my doctoral thesis at the AG Kobold lab. I get to study and work on modular CAR T cell therapy which combines CAR T cells with monoclonal antibodies to further improve the efficacy of CAR T cell therapy while also providing the means to regulate CAR T cell function. Aside from my very interesting research topic I also appreciate the friendly and encouraging working atmosphere that is always present in the lab.

                                                                  After finishing my medical studies, I want to work as a clinician scientist, preferably at LMU Munich.

                                                                  In my free time I enjoy doing ballet, reading, biking and spending time with my friends and family. 

                                                                  Emre Erdogan

                                                                  doctoral researcher (PhD track, BAYCELLator) (since 2023)

                                                                  N Npmünxguvimsful_vfiu:yDziusmi
                                                                  BAYCELLAtor

                                                                  Gordon Hoffmann

                                                                  doctoral researcher (MD track, FöFoLe) (since 2023)

                                                                  xüpmüu züwwvguuvim-ful_vfiuyz,iu/mi

                                                                  Rasmus Müller

                                                                  doctoral researcher (MD track) (since 2023)

                                                                  BgcvfceOfiääipvim-SfulhDvfiuyziutDmi

                                                                  Charlotte Carcopino

                                                                  doctoral researcher (PhD track, BAYCELLator) (since 2023)

                                                                  Hzgpäübbi Hgpyüöluüvimtfulhvfiuyziu mi
                                                                  BAYCELLator
                                                                  Bild von Jakob Harwood

                                                                  Jakob Harwood

                                                                  doctoral researcher (PhD track) (since 2024)

                                                                  QgoüjsZgpéSüümvim/ful+vfiuYyziDWuemi
                                                                  Portrait von Anja Hauptstein

                                                                  Anja Hauptstein

                                                                  doctoral researcher (MD track) (since 2024)

                                                                  FuWkgeZgföbcbiSluviDmtful_vfiuyziuSemi
                                                                  Portrait von Philipp Menauer

                                                                  Philipp Menauer

                                                                  doctoral researcher (MD track) (since 2024)

                                                                  PzlälDöösOSigugfipvim ful_vfiuyziu mYi
                                                                  Portrait von Daria Shvets

                                                                  Daria Shvets

                                                                  doctoral researcher (MD track) (since 2024)

                                                                  MJgplg Rzqibcvim/ful_vfiuyziu mi
                                                                  Portrait      von Thomas Janert

                                                                  Thomas Janert

                                                                  doctoral researcher (MD track) (since 2024)

                                                                  Kzüvgc Qguipbvime;fulrvfiuyziuemi

                                                                  Seoyoung Jang

                                                                  doctoral researcher (MD track) (since 2024)

                                                                  Riüјüfux-Qguxvimeful_vfiuyziue:mi

                                                                  Kathrin Großhauser

                                                                  doctoral researcher (PhD track) (since 2024)

                                                                  ÜgbzplYu,-XpücczgfScipvimsful_vfiuyziuemi

                                                                  Anja Surla

                                                                  Master student (since 2024)

                                                                  FukgsRfpDägvim WfulhvfDiuyziuemi

                                                                  Wendy den Hartog

                                                                  doctoral researcher (PhD track) (since 2024)

                                                                  nUiumјsMiudvinmeful_vdfiuyziu-mi

                                                                  Anna Böhm

                                                                  doctoral researcher (MD track) (since 2024)

                                                                  Lilli Ballheimer

                                                                  doctoral researcher (MD track) (since 2025)

                                                                  Jana Engesser

                                                                  doctoral researcher (MD track) (since 2025)

                                                                  QgugtNuxiccipSvimeful#v,fiuyziutmi

                                                                  Mara Rachel Manieri

                                                                  doctoral researcher (MD track) (since 2025)

                                                                  Philipp Daniel Penovici

                                                                  doctoral researcher (MD track) (since 2025)

                                                                  Simon Delahais

                                                                  doctoral researcher (PhD track) (since 2025)

                                                                  SRlvüusMiägzglcvimsfulrvfiuyziusmi
                                                                  former employees
                                                                • Top Papers

                                                                  Doctoral students as co-authors are underlined (starting in 1998)

                                                                  • Gottschlich A, Thomas M, Grünmeier R, Lesch S, Rohrbacher L, Igl V, Briukhovetska D, Benmebarek MR, Vick B, Dede S, Müller K, Xu T, Dhoqina D, Märkl F, Robinson S, Sendelhofert A, Schulz H, Umut Ö, Kavaka V, Tsiverioti Ch, Carlini E, Nandi S, Strzalkowski T, Lorenzini  T, Stock S, Müller P, Dörr J, Seifert M, Cadilha B, Brabenec R, Röder N, Rataj F, Nüesch M, Modemann F, Wellbrock J, Fiedler W, Kellner Ch, Beltrán E, Herold T, Paquet D,  Jeremias I, von Baumgarten L, Endres S, Subklewe M, Marr C, Kobold S. (2023). Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia. Nature Biotechnology, 41 (11), 1618-1632. doi:10.1038/s41587-023-01684-0. JIF2022=68,2. https://pubmed.ncbi.nlm.nih.gov/36914885/
                                                                  • Briukhovetska, D., Suarez-Gosalvez, J., Voigt, C., Markota, A., Giannou, A. D., Schubel, M., Jobst, J., Zhang, T., Dorr, J., Markl, F., Majed, L., Muller, P. J., May, P., Gottschlich, A., Tokarew, N., Lucke, J., Oner, A., Schwerdtfeger, M., Andreu-Sanz, D., Grunmeier, R., Seifert, M., Michaelides, S., Hristov, M., Konig, L. M., Cadilha, B. L., Mikhaylov, O., Anders, H. J., Rothenfusser, S., Flavell, R. A., Cerezo-Wallis, D., Tejedo, C., Soengas, M. S., Bald, T., Huber, S., Endres, S., & Kobold, S. (2023). T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis. Immunity, 56(1), 143-161 e111. doi:10.1016/j.immuni.2022.12.010. JIF2021=43,4. https://pubmed.ncbi.nlm.nih.gov/36630913/
                                                                  • Briukhovetska, D., Dorr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021). Interleukins in cancer: from biology to therapy. Nature Reviews Cancer, 21(8), 481-499. doi:10.1038/s41568-021-00363-z. JIF2021=69,8. https://pubmed.ncbi.nlm.nih.gov/34083781/
                                                                  • Lesch S, Blumenberg V, Stoiber S, Gottschlich A, Ogonek J, Cadilha B, Dantes Z, Rataj F, Dorman K, Lutz J, Karches C, Heise C, Kurzay M, Larimer B, Grassmann S, Rapp M, Nottebrock A, Kruger S, Tokarew N, Metzger P, Hoerth Ch, Benmebarek MR, Dhoqina D, Gruenmeier R, Seifert M, Oener A, Umut Ö, . . . Rothenfusser S, Duewell P, Koenig L, Schnurr M, Subklewe M, Liss A, Halama N, Reichert M, Mempel T, Endres S, Kobold S. (2021). T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nature Biomedical Engineering, 5 (11), 1246-1260. doi:10.1038/s41551-021-00737-6. JIF2021=29,23. https://www.nature.com/articles/s41551-021-00737-6
                                                                  • Cadilha B, Benmebarek MR, Dorman K, Oener A, Lorenzini T, Obeck H, Väntinnen M, Di Pilato M, Pruessmann JN, Stoiber S, Huynh D, Maerkl F, Seifert M, Manske K, Suarez-Gosalvez J, Zeng Y, Lesch S, Karches CH, Heise C, Gottschlich A, Thomas M, Marr C, Zhang J, Pandey D, Feuchtinger T, Subklewe M, Mempel TR, Endres S, Kobold S. (2021). Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumor. Science Advances, 7 (24). doi:10.1126/sciadv.abi5781. JIF2022=13,6. https://pubmed.ncbi.nlm.nih.gov/34108220/
                                                                  • Benmebarek MR, Cadilha B, Hermman M, Lesch S, Schmitt S, Stoiber S, Darwich A, Augsberger Ch, Brauchle B, Rohrbacher L, Oener A, Seifert M, Schwerdtfeger M, Gottschlich A, Rataj F, Fenn NC, Klein Ch, Subklewe M, Endres S, Hopfner KP, Kobold S. (2021). A modular and controllable T cell therapy platform for acute myeloid leukemia. Leukemia, 35, 2243-2257. JIF2021=12,88. https://pubmed.ncbi.nlm.nih.gov/33414484/
                                                                  • Di Pilato M*, Kfuri-Rubens R*, Pruessmann J*, Ozga AJ*, Messemaker, M, Cadilha B, Sivakumar R, Cianciaruso Ch, Warner RD, Marangoni F, Carrizosa E, Lesch S, Billingsley J, Perez-Ramos D, Zavala F, Rheinbay E, Luster AD, Gerner MY, Kobold S, Pittet MJ, Mempel TR. (2021). CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell, 184 (17), 4512-4530. *contributed equally. doi:10.1016/j.cell.2021.07.015.  JIF2022=66,85. https://www.sciencedirect.com/science/article/abs/pii/S0092867421008564?dgcid=co author
                                                                  • Liu X, Li J, Cadilha B, Markota A, Voigt C, Huang Z, Lin P, Wang D, Juncheng D, Kranz G, Krandick A, Libl D, Zitzelsberger H, Zagorski I, Braselmann H, Pan M, Zhu S, Huang Y, Niedermeyer S, Reichel Ch, Uhl B, Briukhovetska D, Suarez Gosalvez J, Kobold S, Gires O, Wang H. (2019). Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis. Science Advances, 5 (6), eaav4275.doi:10.1126/sciadv.aav4275. JIF2022=13,6. https://pubmed.ncbi.nlm.nih.gov/31223646/

                                                                  • Ferrari de Andrade, L., Tay, R. E., Pan, D., Luoma, A. M., Ito, Y., Badrinath, S., Tsoucas, D., Franz, B., May, K. F., Jr., Harvey, C. J., Kobold, S., Pyrdol, J. W., Yoon, C., Yuan, G. C., Hodi, F. S., Dranoff, G., & Wucherpfennig, K. W. (2018). Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity. Science, 359(6383), 1537-1542. doi:10.1126/science.aao0505. JIF2021=47,73. https://pubmed.ncbi.nlm.nih.gov/29599246/

                                                                  • Voigt C*, May P*, Gottschlich A*, Markota A, Wenk D, Gerlach I, Voigt S, Stathopoulos GT, Arendt K, Heise C, Rataj F, Janssen KP, Königshoff M, Winter H, Himsl I, Thasler W, Schnurr M, Rothenfußer S, Endres S, Kobold S. (2017). Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth. Proceedings of the National Academy of Sciences. 114 (49), 12994-12999. *contributed equally. doi:10.1073/pnas.1705165114. JIF2021=12,77. https://pubmed.ncbi.nlm.nih.gov/29150554/

                                                                  • Kobold* S, Grassmann* S, Chaloupka M, Lampert C, Wenk S, Kraus F, Rapp M, Duewell P, Zeng Y, Schmollinger J, Schnurr M, Endres S#, Rothenfußer S#. (2015). Impact of a new fusion receptor on PD-1-mediated immunosuppression in adoptive T cell therapy. The Journal of the National Cancer Institute, 107. *contributed equally to this study, # share senior authorship. JIF2021=11,81. http://www.ncbi.nlm.nih.gov/pubmed/26105028

                                                                  • Kobold S, Steffen J, Chaloupka M, Grassmann S, Henkel J, Castoldi R, Zeng Y, Chmielewski M, Schmollinger J, Schnurr M, Rothenfußer S, Schendel DJ, Abken H, Sustmann C, Niederfellner CG, Klein C, Bourquin C, Endres S. (2014). Selective bispecific T cell recruiting antibody enhances anti-tumor activity of adoptive T cell transfer. The Journal of the National Cancer Institute. 107:364. JIF2021=11,81. https://pubmed.ncbi.nlm.nih.gov/25424197/

                                                                  • Kobold S, Völk S, Clauditz T, Küpper NJ, Minner S, Tufmann A, Düwell P, Lindner M, Koch I, Heidegger S, Merk M, Rothenfußer S, Schnurr M, Huber RM, Sauter G, Wilczak W, Endres S. (2013). Interleukin-22 is frequently expressed in small-and large- cell lung cancer and promotes growth in chemotherapy-resistant cancer cells. Journal of Thoracic Oncology, 8:1032-1042. JIF2021=20,12. https://pubmed.ncbi.nlm.nih.gov/23774470/

                                                                  All Publications
                                                                  Publications Kobold S
                                                                  Publications Endres S
                                                                • Application

                                                                  We welcome unsolicited applications at all levels: for doctoral students of medicine and natural sciences, research assistant, technician and post-doctoral researcher. Please send your motivation letter, along with your CV and the contact of two references to:

                                                                  cijgcblgusoüjüäDmvim ful_vfiuyziusmi

                                                                  Promotionssprechstunde

                                                                  Die Promotionssprechstunde findet jede Woche Montags zwischen 10 und 11 Uhr statt. Wir bitten um vorheriger Anmeldung unter:

                                                                  cijgcblgu-oüjüä;mvimeful_vfiuyziSu mi

                                                                  Univ.-Prof. Dr. med. Sebastian Kobold bietet Studierenden der Medizin und Naturwissenschaftlicher Fächer eine persönliche Beratung rund um Fragen der Promotion zum Dr. med., Dr. hum. biol, Dr. rer. nat. oder PhD, insbesondere an der medizinischen Fakultät der LMU an. Ziel ist es über Chancen und Hürden der Promotion im Bezug auf die persönliche Situation zu informieren und zur Orientierung zu verhelfen.

                                                                50 Jahre Campus Großhadern - Tag der offenen Tür

                                                                Am Samstag, 14. September 2024, präsentiert sich die LMU Medizin von 10 bis 16 Uhr beim Tag der Offenen Tür am Campus Großhadern mit einem vielfältigen Programm für die gesamte Familie: mit Vorträgen, Führungen, Infoständen und Mitmach-Aktionen. Dazu gibt es ein buntes und spannendes Rahmenprogramm mit Aktivitäten für Kinder, Foodtrucks und Musik.

                                                                mehr Informationen

                                                                Medizinische Klinik und Poliklinik IV - Klinikum der Universität München

                                                                Lindwurmstraße 2a

                                                                80337 München

                                                                Direktor: Prof. Dr. med. Stefan Endres

                                                                Twitter: @KlinPharm

                                                                +49 (0)89 4400-5 7300
                                                                +49 (0)89 4400-5 7330
                                                                • Imprint
                                                                • Data-Safety

                                                                Adresse:

                                                                • Exakte Wegbeschreibung
                                                                Editor login
                                                              • Startseite
                                                              • Einrichtungen
                                                              • Kontakt
                                                              • Presse
                                                              • International Patient Office
                                                                en
                                                                • Deutsch - de
                                                                • English - en

                                                                Abteilung fü...

                                                                • Division Office
                                                                • Research Groups
                                                                  • Division Head, Office, Project Management and Lab Assistance
                                                                  • Kobold Lab
                                                                  • Rothenfußer Lab
                                                                  • König and Schnurr Lab
                                                                  • Anz Lab
                                                                  • Daniel Lab
                                                                • Research
                                                                  • Completed doctoral theses
                                                                  • Doctoral research programs
                                                                  • Habilitations
                                                                  • Alumni professors
                                                                  • Grants
                                                                  • Cooperations
                                                                  • Press releases
                                                                  • Ranking
                                                                  • Themes
                                                                • Publications
                                                                • Patient Care
                                                                • Teaching
                                                                • Medical Specialties
                                                                • Events
                                                                • News
                                                                • i-Target 2.0
                                                                  • Team Jobs
                                                                  • Seminar Program
                                                                  • Graduate Students
                                                                  • Partnership Harvard Medical School
                                                                  • Annual Retreats
                                                                  • i-Target 1.0
                                                                    • Research Groups
                                                                      • Research area 1: Targeted cellular therapy
                                                                      • Research area 2: Targeted antibody therapy
                                                                      • Research area 3: Targeted immunomodulatory therapy
                                                                    • Project Leaders
                                                                    • Graduate Students
                                                                    • Publications
                                                                    • Annual Retreats
                                                                      • 2016
                                                                        • Introduction
                                                                        • Invitation Letter
                                                                        • Program
                                                                        • Confirmed Speakers
                                                                        • Conference Venue
                                                                    • Seminars
                                                                    • Team Jobs
                                                                    • Partnership Harvard Medical School